BiotechTube
Home/Clear Scientific/Peter Howe
PH

Peter Howe

Chief Financial Officer

Clear Scientific

Therapeutic Areas

Substance Use Disorder & OverdoseMetabolic DisordersNeurodegenerative Diseases

Clear Scientific Pipeline

DrugIndicationPhase
Overdose Reversal (Methamphetamine/Fentanyl)Drug Overdose ReversalPre-clinical
Metabolic/CNS DysfunctionConditions caused by excess harmful metabolitesPre-clinical

Leadership Team at Clear Scientific

SS
Shekar Shetty
Chief Executive Officer
XL
Xinhua Li, PhD
EVP, Drug Development
JM
John Marota, MD, PhD
Medical Director
MZ
Mitch Zakin, PhD
EVP, Innovation
WH
Winston Henderson, JD
General Counsel
View full Clear Scientific profile